Is a 500 ng/mL or 1000 ng/mL cutoff standard for workplace amphetamine urine screening dip cards?
Short answer
A 500 ng/mL cutoff is the standard threshold for federally regulated workplace amphetamine testing, while a 1000 ng/mL cutoff is widely used in non-regulated programs. Regulated testing mandates the lower 500 ng/mL level to detect drug use across an extended 48- to 72-hour window. Non-regulated employers often select the 1000 ng/mL cutoff to reduce false-positive screens caused by common over-the-counter medications.
A 500 ng/mL cutoff is the current federal standard for workplace amphetamine urine screening under SAMHSA guidelines, whereas a 1000 ng/mL cutoff remains widely used in non-regulated workplace screening programs.
Workplace drug testing programs must balance detecting illicit drug use against reducing false-positive results from common prescription and over-the-counter medications. When federal regulators updated testing standards in 2010, the mandated immunoassay screening threshold dropped to capture extended detection windows across standard 10-panel and 14-panel urine dip cards.
If you only do one thing: Select a 500 ng/mL cutoff dip card for federally regulated programs or extended detection windows, and choose 1000 ng/mL if your policy prioritizes minimizing non-DOT over-the-counter cross-reactivity.
- SAMHSA Federal Standard: The Substance Abuse and Mental Health Services Administration (SAMHSA) mandates a 500 ng/mL (nanograms per milliliter) initial immunoassay screening cutoff for federal employee and Department of Transportation (DOT) testing programs.
- Legacy 1000 ng/mL Baseline: Many general, non-regulated workplace dip cards continue to use 1000 ng/mL, the pre-2010 federal benchmark designed around a shorter 24- to 48-hour detection window.
- Window of Detection: A 500 ng/mL screening card extends the detection window to roughly 48 to 72 hours post-use, detecting lower metabolite concentrations as the body clears the drug.
- Confirmatory Thresholds: Any presumptive positive screen at the 500 ng/mL level requires laboratory confirmation using gas chromatography-mass spectrometry (GC-MS) at a secondary 250 ng/mL cutoff level.
- Panel Configurations: Point-of-care formats, such as multi-panel urine drug test dip cards (including 10-panel and 14-panel configurations), list individual analyte cutoffs directly on product foil packaging and package inserts.
- Watch out for: Over-the-counter cross-reactivity from common decongestants (such as pseudoephedrine) and prescription stimulants that can trigger presumptive positive screens at lower cutoff levels.
- Watch out for: Testing policy mismatch, where an employer tests at a 500 ng/mL cutoff without establishing a formal Medical Review Officer (MRO) review process for verified prescriptions.
- Watch out for: Timing and temperature errors, such as reading dip card test lines outside the specified 5-minute result window, which can generate invalid interpretations.
Review your organization's written drug testing policy or consult an employment compliance professional to verify whether a 500 ng/mL or 1000 ng/mL cutoff matches your mandated testing protocol.